Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -50.439\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) CCN(CC)CCn1c(SCC(=O)NCc2ccco2)nc2c(sc3ccccc32)c1=O
(b) CCOc1ccc(S(=O)(=O)NCCC(=O)NCCOc2ccccc2)cc1
(c) COc1ccc(OC)c(-c2nc(C(=O)NCCCN3CCOCC3)cc3c2[nH]c2ccccc23)c1
(d) O=C(Cn1cnc2sc3c(c2c1=O)CCCC3)NCC(=O)Nc1ccc(F)cc1F
(e) CCN1CCN(C(=S)Nc2cc(S(=O)(=O)N(CC)CC)ccc2C)CC1
Answer: a. CCN(CC)CCn1c(SCC(=O)NCc2ccco2)nc2c(sc3ccccc32)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC)CCn1c(SCC(=O)NCc2ccco2)nc2c(sc3ccccc32)c1=O
CCN(CC)CCn1c(SCC(=O)NCc2ccco2)nc2c(sc3ccccc32)c1=O
2-[[3-[2-(diethylamino)ethyl]-4-oxo-[1]benzothiolo[3,2-d]pyrimidin-2-yl]sulfanyl]-N-(furan-2-ylmethyl)acetamide